French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends

BACKGROUND: France is one of the European countries that spend the most on oncology drugs. To keep pharmaceutical expenditure under control, Health Authorities highly scrutinize market access of costly medicines. OBJECTIVE: To assess current and future trends in French health technology assessment (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chouaid, Christos, Borget, Isabelle, Braun, Eric, Bazil, Marie-Laure, Schaetz, Dominique, Rémuzat, Cécile, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961733/
https://www.ncbi.nlm.nih.gov/pubmed/26830301
http://dx.doi.org/10.1007/s11523-015-0411-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961733/
https://www.ncbi.nlm.nih.gov/pubmed/26830301
http://dx.doi.org/10.1007/s11523-015-0411-8

Ejemplares similares